The CDC is conducting market research to identify suppliers capable of providing a Luminex Flexmap3D multiplexing instrument with xPONENT 4.3 software, a brand-name requirement for analyzing up to 500 biological targets simultaneously. Responses to this notice are due by 11 June 2026 at 5:00 PM (EST), and no budget amount is specified. The location for performance of services is not mentioned. Based on responses, the acquisition may be set aside for small businesses or competed full and open, with potential for multiple awards. Interested parties should submit capability statements to the Contract Specialist via email.